Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Harris

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Blood|January 31, 2012
Plasma biomarkers of lower gastrointestinal and liver acute GVHDAndrew C Harris, James L M Ferrara, Thomas M Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Bone Marrow Transplantation|November 24, 2021
Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHDGabrielle Meyers, Mehdi Hamadani, Michael Martens, et al.
Cytotherapy|March 2, 2024
Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantationHannah Major-Monfried, Kinga Hosszu, Devin P McAvoy, et al.
Cytotherapy|February 13, 2024
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patientsMadhavi Lakkaraja, Audrey Mauguen, Farid Boulad, et al.
Transplantation and Cellular Therapy|December 19, 2024
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy DiscontinuationNeel S Bhatt, Andrew C Harris, Lev Gorfinkel, et al.
The Journal of Allergy and Clinical Immunology|June 27, 2023
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutationsBinni Kunvarjee, Alan Bidgoli, Rebecca Pellett Madan, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Blood|January 31, 2012
Plasma biomarkers of lower gastrointestinal and liver acute GVHDAndrew C Harris, James L M Ferrara, Thomas M Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Bone Marrow Transplantation|November 24, 2021
Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHDGabrielle Meyers, Mehdi Hamadani, Michael Martens, et al.
Cytotherapy|March 2, 2024
Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantationHannah Major-Monfried, Kinga Hosszu, Devin P McAvoy, et al.
Cytotherapy|February 13, 2024
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patientsMadhavi Lakkaraja, Audrey Mauguen, Farid Boulad, et al.
Transplantation and Cellular Therapy|December 19, 2024
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy DiscontinuationNeel S Bhatt, Andrew C Harris, Lev Gorfinkel, et al.
The Journal of Allergy and Clinical Immunology|June 27, 2023
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutationsBinni Kunvarjee, Alan Bidgoli, Rebecca Pellett Madan, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Pageof 10